We are excited to announce we are expanding our scope of lessons.
Our new research partnership with the National Human Genome Research Institute will focus on ADHD Virtual Reality Cognitive Therapy.
We have entered into a collaborative research and development agreement (CRADA) with the National Human Genome Research Institute (NHGRI), part of the National Institutes of Health (NIH).
Under the CRADA, Floreo and NHGRI will jointly develop and pilot immersive virtual reality (VR) modules focused on improving cognitive deficits frequently implicated in attention deficit hyperactivity disorder (ADHD).
Read more about our new partnership here.
.png?width=250&height=114&name=Untitled%20(14).png)